Synthesis and biological activities of novel β-Carbolines as PDE5 inhibitors
Authors:
- 28 February 2003
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 13 (4) , 761-765
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Phosphodiesterase 5 inhibitors: current status and potential applicationsNature Reviews Drug Discovery, 2002
- Novel, Potent, and Selective Phosphodiesterase 5 Inhibitors: Synthesis and Biological Activities of a Series of 4-Aryl-1-isoquinolinone DerivativesJournal of Medicinal Chemistry, 2001
- Substituted Pyrazolopyridines as Potent and Selective PDE5 Inhibitors: Potential Agents for Treatment of Erectile DysfunctionJournal of Medicinal Chemistry, 2001
- Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functionsCurrent Opinion in Cell Biology, 2000
- Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11AProceedings of the National Academy of Sciences, 2000
- N-3-Substituted Imidazoquinazolinones: Potent and Selective PDE5 Inhibitors as Potential Agents for Treatment of Erectile DysfunctionJournal of Medicinal Chemistry, 2000
- Cyclic GMP Phosphodiesterase-5: Target of SildenafilJournal of Biological Chemistry, 1999
- Section Review Cardiovascular & Renal: Phosphodiesterase 5 inhibitors in development for cardiovascular therapyExpert Opinion on Investigational Drugs, 1996
- Sildenafil (VIAGRATM), a potent and selective inhibitor of type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunctionBioorganic & Medicinal Chemistry Letters, 1996
- Cyclic nucleotide phosphodiesterases: functional implications of multiple isoformsPhysiological Reviews, 1995